Related Experiment Video
Updated: Jun 19, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Doxorubicin exerts cytotoxic effects through cell cycle arrest and Fas-mediated cell death
Hye-Sun Kim1, Yong-Soo Lee, Dong-Ku Kim
1Graduate School of Life Science and Biotechnology, Pochon CHA University, CHA Stem Cell Institute, Seoul, Korea.
Abstract:
Doxorubicin (DOX) is involved in the induction of DNA damage, inhibition of cell proliferation, impairment of mitochondria, and cell death. To determine the biological effects of DOX in murine lymphocytes, we analyzed cell proliferation, cell cycle status, and apoptosis in Ba/F3 and EL4 lymphoid cells. DOX treatment resulted in significant cellular morphological alteration with increased intracellular granularity and cell size. DOX inhibited cell proliferation through cell cycle arrest at the G(2)/M phase as well as by cell death. In addition, DOX treatment dramatically upregulated Fas expression and enhanced caspase activation to promote intracellular apoptotic signaling for cell death. Treatment with an agonistic antibody stimulated Fas and accelerated the cell death effects. In conclusion, we demonstrate that DOX induces cell cycle arrest and apoptosis by increased Fas expression and ultimately results in enhanced cell death.
Insights
Doxorubicin (DOX) induces cell cycle arrest and apoptosis in murine lymphocytes by upregulating Fas expression and activating caspases, leading to significant cell death. This study clarifies DOX
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Doxorubicin (DOX) is a widely used chemotherapy agent known to induce DNA damage, inhibit cell proliferation, and cause cell death.
- The precise mechanisms by which DOX affects lymphoid cells, particularly regarding apoptosis induction, require further elucidation.
Purpose of the Study:
- To investigate the biological effects of Doxorubicin (DOX) on murine lymphoid cells.
- To analyze the impact of DOX on cell proliferation, cell cycle progression, and apoptosis in Ba/F3 and EL4 cells.
Main Methods:
- Treatment of Ba/F3 and EL4 murine lymphoid cells with Doxorubicin (DOX).
- Analysis of cellular morphology, cell proliferation, cell cycle status (G(2)/M phase arrest), Fas expression, and caspase activation.
- Assessment of apoptosis induction using specific assays and an agonistic antibody to stimulate Fas.
Main Results:
- Doxorubicin (DOX) treatment caused significant morphological changes, including increased granularity and cell size.
- DOX inhibited cell proliferation via cell cycle arrest at the G(2)/M phase and induced cell death.
- DOX treatment upregulated Fas expression and enhanced caspase activation, promoting apoptotic signaling and cell death.
Conclusions:
- Doxorubicin (DOX) effectively induces cell cycle arrest and apoptosis in murine lymphocytes.
- Increased Fas expression and caspase activation are key mechanisms underlying DOX-induced cell death.
- DOX treatment ultimately results in enhanced cell death in lymphoid cells through apoptotic pathways.
Related Concept Videos
The Extrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
